Analystreport

ContraVir Pharmaceuticals Inc (NYSE: HEPA) was downgraded by analysts at Zacks Investment Research from a "buy" rating to a "hold" rating.

Hepion Pharmaceuticals, Inc.  (HEPA) 
Last hepion pharmaceuticals, inc. earnings: 11/14 05:17 pm Check Earnings Report